The effect of trichlormethiazide in autosomal dominant polycystic kidney disease patients receiving tolvaptan: a randomized crossover controlled trial

Kiyotaka Uchiyama(Japanese Red Cross Medical Center), Yoshitaka Ishibashi(Japanese Red Cross Medical Center), Chigusa Kitayama(Sendai Shakai Hoken Hospital), Akane Yanai(New Tokyo Hospital)
Scientific Reports
September 3, 2021
Cited by 27


Related Papers